FR2121758B1 - - Google Patents

Info

Publication number
FR2121758B1
FR2121758B1 FR7200832A FR7200832A FR2121758B1 FR 2121758 B1 FR2121758 B1 FR 2121758B1 FR 7200832 A FR7200832 A FR 7200832A FR 7200832 A FR7200832 A FR 7200832A FR 2121758 B1 FR2121758 B1 FR 2121758B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7200832A
Other languages
French (fr)
Other versions
FR2121758A1 (enExample
Inventor
Esch A M Von
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of FR2121758A1 publication Critical patent/FR2121758A1/fr
Application granted granted Critical
Publication of FR2121758B1 publication Critical patent/FR2121758B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7200832A 1971-01-11 1972-01-11 Expired FR2121758B1 (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10566471A 1971-01-11 1971-01-11

Publications (2)

Publication Number Publication Date
FR2121758A1 FR2121758A1 (enExample) 1972-08-25
FR2121758B1 true FR2121758B1 (enExample) 1975-10-10

Family

ID=22307104

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7200832A Expired FR2121758B1 (enExample) 1971-01-11 1972-01-11

Country Status (8)

Country Link
US (1) US3681326A (enExample)
JP (1) JPS5629677B1 (enExample)
AU (1) AU459269B2 (enExample)
CA (1) CA955593A (enExample)
DE (1) DE2200940C2 (enExample)
FR (1) FR2121758B1 (enExample)
GB (1) GB1336263A (enExample)
SE (1) SE375535B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3855203A (en) * 1973-05-03 1974-12-17 Abbott Lab 4{41 -o-sulfonyl erythromycin-9-o-oxime derivatives
US3979511A (en) * 1974-05-23 1976-09-07 Abbott Laboratories Inhibitors of reverse transcriptase enzymes
US3963696A (en) * 1975-02-21 1976-06-15 Abbott Laboratories 6,6A-AND 6,7-Anhydroerythromycin B and derivatives thereof
YU43006B (en) * 1981-03-06 1989-02-28 Pliva Pharm & Chem Works Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof
US4526889A (en) * 1982-11-15 1985-07-02 Pfizer Inc. Epimeric azahomoerythromycin A derivative, intermediates and method of use
ES552858A1 (es) 1985-03-12 1987-11-01 Beecham Group Plc Un procedimiento para la preparacion de derivados de eritromicina.
US5932710A (en) 1997-12-01 1999-08-03 Abbott Laboratories Process for preparing 6-O-alkyl-9-oxime erythromycin B
US20020187944A1 (en) * 2001-03-21 2002-12-12 Hung Paul Porwen Inhibition of human immunodeficiency virus reverse transcriptase

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU31319B (en) * 1967-08-03 1973-04-30 Pliva Pharm & Chem Works Postupak za dobijanje acil derivata eritromicin oksima
GB1100504A (en) * 1967-08-16 1968-01-24 Pliva Pharm & Chem Works Erythromycin oxime and 9-amino-3-o-cladinosyl-5-o-desosaminyl-6,11,12-trihydroxy-2,4,6,8,10,12-hexamethylpentadecane-13-olide
ZA695765B (en) * 1968-08-29 1971-03-31 Lilly Co Eli Erythromycylamine and process for preparing same

Also Published As

Publication number Publication date
CA955593A (en) 1974-10-01
DE2200940C2 (de) 1981-10-29
JPS5629677B1 (enExample) 1981-07-09
AU3699871A (en) 1973-06-21
SE375535B (enExample) 1975-04-21
US3681326A (en) 1972-08-01
FR2121758A1 (enExample) 1972-08-25
AU459269B2 (en) 1975-03-05
GB1336263A (en) 1973-11-07
DE2200940A1 (de) 1972-07-20

Similar Documents

Publication Publication Date Title
FR2121758A1 (enExample)
AR196074A1 (enExample)
AU2691671A (enExample)
AU3102871A (enExample)
AU2684071A (enExample)
AU2726271A (enExample)
AU2742671A (enExample)
AU2894671A (enExample)
AU2941471A (enExample)
AU2952271A (enExample)
AU3005371A (enExample)
AU2907471A (enExample)
AU2854371A (enExample)
AU2875571A (enExample)
AU2684171A (enExample)
AU2706571A (enExample)
AU2724971A (enExample)
AU2740271A (enExample)
AU2755871A (enExample)
AU2836771A (enExample)
AU2880771A (enExample)
AU2885171A (enExample)
AU2837671A (enExample)
AU2927871A (enExample)
AU2930871A (enExample)

Legal Events

Date Code Title Description
ST Notification of lapse